Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 8—August 2014


Leptospirosis-Associated Hospitalizations, United States, 1998–2009

CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at; (4) view/print certificate.

Release date: July 16, 2014; Expiration date: July 16, 2015

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Analyze the clinical presentation of leptospirosis

2. Evaluate the epidemiology of leptospirosis-associated hospitalizations in the United States

3. Distinguish the time of year when leptospirosis-associated hospitalizations are most common

4. Compare the clinical impact of leptospirosis-associated hospitalizations vs nonleptospirosis infectious disease hospitalizations

CME Editor

Claudia Chesley, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Claudia Chesley has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Associate Professor and Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed the following financial relationships: Served as an advisor or consultant for McNeil Pharmaceuticals.


Disclosures: Rita M. Traxler, MHS; Laura S. Callinan, MPH; Robert C. Holman, MS; Claudia Steiner, MD, MPH; and Marta A. Guerra, DVM, PhD, MPH, have disclosed no relevant financial relationships.


Article Navigation